Noah D. Carrillo

Noah D. Carrillo

Auto-generated profile, based on publicly available information

Noah D. Carrillo

University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, School of Medicine and Public Health; 1111 Highland Avenue, Madison, WI 53705, USA; Department of Medicine, University of Wisconsin-Madison, School of Medicine and Public Health; 1111 Highland Avenue, Madison, WI 53705, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
CCChangliang Chen
Changliang Chen
NCNoah D. Carrillo
Noah D. Carrillo
MCMo Chen
Mo Chen
TWTianmu Wen
Tianmu Wen
PAPoorwa Awasthi
Poorwa Awasthi
VCVincent L. Cryns
Vincent L. Cryns
Reactive oxygen species (ROS) are generated by aerobic metabolism, and their deleterious effects are buffered by the cellular antioxidant response, which prevents oxidative stress. The nuclear factor erythroid 2-related factor 2 (NRF2) is a master transcriptional regulator of the antioxidant response. Basal levels of NRF2 are kept low by ubiquitin-dependent degradation of NRF2 by E3 ligases, including the Kelch-like ECH-associated protein 1 (KEAP1). Here, we show that the stability and function of NRF2 is regulated by the type I phosphatidylinositol phosphate kinase γ (PIPKIγ), which binds NRF2 and is required to stably couple phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) to NRF2 in response to oxidative stress. Stress also induces the interaction of the small heat shock protein HSP27 and NRF2 and this interaction is enhanced by PtdIns(4,5)P2. Silencing PIPKIγ or HSP27 destabilizes NRF2, reduces expression of its target gene HO-1, and sensitizes cells to oxidative stress. These data demonstrate an unexpected collaboration between phosphoinositides, which are stably coupled to NRF2, and HSP27, which is recruited to NRF2 by a phosphoinositide-dependent mechanism to regulate NRF2 stability and function. These findings also point to PIPKIγ and HSP27 as drug targets to destabilize NRF2 in cancer.

9 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
NCNoah D. Carrillo
Noah D. Carrillo
MCMo Chen
Mo Chen
TWTianmu Wen
Tianmu Wen
PAPoorwa Awasthi
Poorwa Awasthi
CSColin Sterling
Colin Sterling
RARichard A. Anderson
Richard A. Anderson
Summary: Phosphoinositide (PIP n ) messengers are present in non-membranous regions of nuclei where they are assembled into a phosphatidylinositol (PI) 3-kinase (PI3K)/Akt pathway that is distinct from the cytosolic membrane-localized pathway. In the nuclear pathway, PI kinases/phosphatases bind the p53 tumor suppressor protein (wild-type and mutant) to generate p53-PIP n complexes (p53-PIP n signalosome) that activate Akt by a PI3,4,5P 3 -dependent mechanism in non-membranous regions of the nucleus. This pathway is dependent on a source of nuclear PIP n s that is poorly characterized. Here we report that a subset of PI transfer proteins (PITPs), which transport PI between membranes to enable membrane-localized PIP n synthesis, also interact with p53 in the nucleus upon genotoxic stress. Class I PITPs (PITPα/β) specifically supply the PI required for the generation of p53-PIP n complexes and subsequent signaling in the nucleus. Additionally, the PI 4-kinase PI4KIIα binds to p53 and the PITPs to catalyze the formation of p53-PI4P. p53-PI4P is then sequentially phosphorylated to synthesize p53-PIP n complexes that regulate p53 stability, nuclear Akt activation and genotoxic stress resistance. In this way, PITPα/β and PI4KIIα bind p53 and collaborate to initiate p53-PIP n signaling by mechanisms that require PI transfer by PITPα/β and the catalytic activity of PI4KIIα. Moreover, the identification of these critical upstream regulators of p53-PIP n signaling point to PITPα/β and PI4KIIα as potential therapeutic targets in this pathway for diseases like cancer. In Breif: Phosphatidylinositol transfer proteins and a PI 4-kinase initiate nuclear p53-PIP n signaling in membrane-free regions.

27 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
CCChangliang Chen
Changliang Chen
MCMo Chen
Mo Chen
TWTianmu Wen
Tianmu Wen
PAPoorwa Awasthi
Poorwa Awasthi
NCNoah D. Carrillo
Noah D. Carrillo
VCVincent L. Cryns
Vincent L. Cryns
Reactive oxygen species (ROS) are generated by aerobic metabolism, and their deleterious effects are buffered by the cellular antioxidant response, which prevents oxidative stress. The nuclear factor erythroid 2-related factor 2 (NRF2) is a master transcriptional regulator of the antioxidant response. Basal levels of NRF2 are kept low by ubiquitin-dependent degradation of NRF2 by E3 ligases, including the Kelch-like ECH-associated protein 1 (KEAP1). Here, we show that the stability and function of NRF2 is regulated by the type I phosphatidylinositol phosphate kinase γ (PIPKIγ), which binds NRF2 and transfers its product phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ) to NRF2. PtdIns(4,5)P 2 binding recruits the small heat shock protein HSP27 to the complex. Silencing PIPKIγ or HSP27 destabilizes NRF2, reduces expression of its target gene HO-1, and sensitizes cells to oxidative stress. These data demonstrate an unexpected role of phosphoinositides and HSP27 in regulating NRF2 and point to PIPKIγ and HSP27 as drug targets to destabilize NRF2 in cancer. In brief: Phosphoinositides are coupled to NRF2 by PIPKIγ, and HSP27 is recruited and stabilizes NRF2, promoting stress-resistance.

5 May 2026 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NCNoah D. Carrillo
Noah D. Carrillo
MCMo Chen
Mo Chen
PAPoorwa Awasthi
Poorwa Awasthi
TWTianmu Wen
Tianmu Wen
XCXiangqin Chen
Xiangqin Chen
RARichard A. Anderson
Richard A. Anderson
Phosphoinositide (PIPn) lipid second messengers in membranes regulate numerous cellular processes. In the cytosol, the phosphatidylinositol (PI) 3-kinase (PI3K)/Akt pathway is scaffolded on IQGAP1 to facilitate the activation of Akt by the synthesis of PI3,4,5P3. In the nucleus, PIPn signaling occurs in compartments separate from membranes by stably linking PIPns to nuclear proteins. While several of these proteins have been identified, understanding the extent and impact of protein-linked PIPn signaling warrants further investigation. The tumor suppressor p53, was shown in the companion paper to be regulated by PI transfer proteins (PITPs) and a PI 4-kinase (PI4KIIα), which are required to form p53-PIPn complexes that assemble a nuclear PI3K/Akt pathway. Here we report that class I PITPs (PITPα/β) and PI4KIIα initiate PIPn linkages to many different proteins. PITPα/β and PI4KIIα accumulate in the nucleoplasm in response to stress and are necessary to synthesize nuclear PIPns linked to proteins. These PITPα/β-dependent protein-PIPn complexes are detected by metabolically labeling cells with the PIPn precursor [3H]-myo-inositol and resist denaturation and SDS-PAGE, indicating that these protein-PIPn complexes represent a putative posttranslational modification. Proteomic and gene set enrichment analysis of proteins that are linked to PI4,5P2 reveals an emerging PIPn-linked proteome (PIPylome) regulated by PITPα/β and enriched in proteins that play key functional roles in metabolism, cell motility/division, and the DNA damage response. The PIPn-linked proteome represents a third messenger signaling paradigm distinct from the canonical membrane-localized pathway whereby linked PIPn messengers regulate protein function.

8 May 2026 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NCNoah D. Carrillo
Noah D. Carrillo
MCMo Chen
Mo Chen
PAPoorwa Awasthi
Poorwa Awasthi
TWTianmu Wen
Tianmu Wen
XYXue Yang
Xue Yang
RARichard A. Anderson
Richard A. Anderson
Phosphoinositide (PIPn) messengers are present in non-membranous regions of nuclei where they are assembled into a phosphatidylinositol (PI) 3-kinase (PI3K)/Akt pathway that is distinct from the cytosolic membrane-localized pathway. In one nuclear pathway, PI kinases/phosphatases bind the p53 tumor suppressor protein (wild-type and mutant) to generate p53-PIPn complexes (p53-PIPn signalosome) that activate Akt by a PI3,4,5P3-dependent mechanism in non-membranous regions of the nucleus. This pathway is dependent on a source of nuclear PIPns that is poorly characterized. Here we report that a subset of PI transfer proteins (PITPs), which transport PI between membranes to enable membrane-localized PIPn synthesis, also interact with p53 in the nucleus upon genotoxic stress. Class I PITPs (PITPα/β) specifically supply the PI required for the generation of p53-PIPn complexes and subsequent p53 signaling in the nucleus. The PI 4-kinase PI4KIIα binds to p53 and together with the PITPs are necessary for the formation of p53-PI4P. p53-PI4P is then sequentially phosphorylated to synthesize p53-PIPn complexes that regulate p53 stability, nuclear Akt activation and genotoxic stress resistance. In this pathway, PITPα/β and PI4KIIα bind p53 and collaborate to initiate p53-PIPn signaling by mechanisms that require PI transfer by PITPα/β and the catalytic activity of PI4KIIα. Moreover, the identification of these critical upstream regulators of p53-PIPn signaling point to PITPα/β and PI4KIIα as potential therapeutic targets in this pathway for mutant p53 driven cancers.

3 February 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MWMorgan T. Walcheck
Morgan T. Walcheck
PSPatrick B. Schwartz
Patrick B. Schwartz
NCNoah D. Carrillo
Noah D. Carrillo
KMKristina A. Matkowsky
Kristina A. Matkowsky
MNManabu Nukaya
Manabu Nukaya
SRSean M. Ronnekleiv-Kelly
Sean M. Ronnekleiv-Kelly
Objectives: The pathogenesis of pancreas cancer (PDAC) remains poorly understood, hindering efforts to develop a more effective therapy for PDAC. Recent discoveries show the aryl hydrocarbon receptor (AHR) plays a crucial role in the pathogenesis of several cancers, and can be targeted for therapeutic effect. However, its involvement in PDAC remains unclear. Therefore, we evaluated the role of AHR in the development of PDAC in vivo . Methods: We created a global AHR-null, mutant Kras -driven PDAC mouse model (A -/- KC) and evaluated the changes in PDAC precursor lesion formation (Pan-IN 1, 2, and 3) and associated fibro-inflammation between KC and A -/- KC at 5 months of age. We then examined the changes in the immune microenvironment followed by single-cell RNA-sequencing analysis to evaluate concomitant transcriptomic changes. Results: We found a significant increase in PanIN-1 lesion formation and PanIN-1 associated fibro-inflammatory infiltrate in A -/- KC vs KC mice. This was associated with significant changes in the adaptive immune system, particularly a decrease in the CD4+/CD8+ T-cell ratio, as well as a decrease in the T-regulatory/Th17 T-cell ratio suggesting unregulated inflammation. Conclusion: These findings show the loss of AHR results in heightened Kras -induced PanIN formation, through modulation of immune cells within the pancreatic tumor microenvironment.